 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol
IDs
|
|
|
| |
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
|
|
|
|
Phase IV
|
|
|
|
AVO108943
NCT00470834
|
|
| |
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
|
|
|
|
Phase III, Phase II
|
|
|
|
001-0015-211
NCT00127387
|
|
| |
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
|
|
|
|
Phase III
|
|
|
|
MDA-ID-00156
NCI-3410, 3410, NCT00024167
|
|
| |
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
|
|
|
|
Phase III
|
|
|
|
CALGB-90202
ECOG-CALGB-90202, NCT00079001, SWOG-CALGB-90202, CAN-NCIC-PRC2
|
|
| |
Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
|
|
|
|
Phase III
|
|
|
|
SWOG-S0421
S0421, NCT00134056
|
|
| |
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
|
|
|
|
Phase III
|
|
|
|
ECOG-E3805
E3805, NCT00309985
|
|
| |
Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer
|
|
|
|
Phase III
|
|
|
|
ROLL-GUP-0205-1
UCLA-0507059-01, NCT00336934
|
|
| |
Double-Blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Men With Hormone-Refractory Prostate Cancer
|
|
|
|
Phase III
|
|
|
|
20050103
NCT00321620
|
|
| |
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
|
|
|
|
Phase III
|
|
|
|
NCCTG-N0574
N0574, ACOSOG-N0574, NCT00377156
|
|
| |
A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Subjects With a Rising PSA
|
|
|
|
Phase III
|
|
|
|
XRP6976J/3503
EudraCT#:2007-000323-17, NCT00514917
|
|
